rs11623956

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.408C>T​(p.His136His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.076 in 1,614,004 control chromosomes in the GnomAD database, including 5,285 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 340 hom., cov: 32)
Exomes 𝑓: 0.078 ( 4945 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.14

Publications

7 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 14-64803673-G-A is Benign according to our data. Variant chr14-64803673-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257111.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0895 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.408C>T p.His136His synonymous_variant Exon 4 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.408C>T p.His136His synonymous_variant Exon 4 of 36 NM_001355436.2 ENSP00000495909.1
SPTBENST00000389722.7 linkc.408C>T p.His136His synonymous_variant Exon 3 of 35 2 ENSP00000374372.3
SPTBENST00000389720.4 linkc.408C>T p.His136His synonymous_variant Exon 4 of 32 5 ENSP00000374370.4

Frequencies

GnomAD3 genomes
AF:
0.0592
AC:
8995
AN:
152028
Hom.:
340
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0154
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0531
Gnomad ASJ
AF:
0.0527
Gnomad EAS
AF:
0.00405
Gnomad SAS
AF:
0.0294
Gnomad FIN
AF:
0.0779
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0914
Gnomad OTH
AF:
0.0475
GnomAD2 exomes
AF:
0.0609
AC:
15316
AN:
251388
AF XY:
0.0621
show subpopulations
Gnomad AFR exome
AF:
0.0130
Gnomad AMR exome
AF:
0.0364
Gnomad ASJ exome
AF:
0.0508
Gnomad EAS exome
AF:
0.00484
Gnomad FIN exome
AF:
0.0766
Gnomad NFE exome
AF:
0.0906
Gnomad OTH exome
AF:
0.0614
GnomAD4 exome
AF:
0.0777
AC:
113600
AN:
1461858
Hom.:
4945
Cov.:
32
AF XY:
0.0770
AC XY:
55962
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0120
AC:
402
AN:
33478
American (AMR)
AF:
0.0390
AC:
1744
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0520
AC:
1359
AN:
26136
East Asian (EAS)
AF:
0.00249
AC:
99
AN:
39700
South Asian (SAS)
AF:
0.0297
AC:
2564
AN:
86258
European-Finnish (FIN)
AF:
0.0783
AC:
4183
AN:
53418
Middle Eastern (MID)
AF:
0.0451
AC:
260
AN:
5764
European-Non Finnish (NFE)
AF:
0.0890
AC:
99021
AN:
1111984
Other (OTH)
AF:
0.0657
AC:
3968
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
6242
12484
18725
24967
31209
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3462
6924
10386
13848
17310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0591
AC:
8992
AN:
152146
Hom.:
340
Cov.:
32
AF XY:
0.0583
AC XY:
4332
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0153
AC:
637
AN:
41500
American (AMR)
AF:
0.0530
AC:
810
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0527
AC:
183
AN:
3472
East Asian (EAS)
AF:
0.00406
AC:
21
AN:
5172
South Asian (SAS)
AF:
0.0295
AC:
142
AN:
4820
European-Finnish (FIN)
AF:
0.0779
AC:
825
AN:
10586
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0914
AC:
6214
AN:
67994
Other (OTH)
AF:
0.0470
AC:
99
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
438
875
1313
1750
2188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0720
Hom.:
470
Bravo
AF:
0.0541
Asia WGS
AF:
0.0210
AC:
74
AN:
3478
EpiCase
AF:
0.0864
EpiControl
AF:
0.0848

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
5.0
DANN
Benign
0.37
PhyloP100
-1.1
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11623956; hg19: chr14-65270391; API